Bowen Hanes & Co’s Boston Scientific BSX Stock Holding History

Bowen Hanes & Co’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$662K	Sell	10,550 -2,620	-20%	-$210K	0.02%	123
2025 Q4	$1.26M	Sell	13,170 -28,655	-69%	-$2.81M	0.03%	103
2025 Q3	$4.08M	Sell	41,825 -372,455	-90%	-$38.6M	0.1%	77
2025 Q2	$44.5M	Buy	414,280 +8,220	+2%	+$832K	1.12%	39
2025 Q1	$41M	Buy	406,060 +48,995	+14%	+$4.93M	1.14%	41
2024 Q4	$31.9M	Buy	+357,065	New	+$31.4M	0.86%	48

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bowen Hanes & Co's BSX Position: Q1 2026 in Review

Bowen Hanes & Co reduced its Boston Scientific (BSX) stake by 20% in Q1 2026, selling an estimated $210K and leaving 10,550 shares worth $662K. The position accounts for 0.02% of the portfolio, ranked #123.

Bowen Hanes & Co first reported a position in BSX in Q4 2024 and has held it in 6 quarters since. The position peaked at $44.5M in Q2 2025. 1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Bowen Hanes & Co held 10,550 shares of Boston Scientific worth $662K as of Q1 2026.
Bowen Hanes & Co sold 2,620 Boston Scientific shares in Q1 2026, an estimated $210K.
Boston Scientific made up 0.02% of Bowen Hanes & Co's portfolio in Q1 2026, its #123 holding.
Bowen Hanes & Co first reported a position in Boston Scientific in Q4 2024 and has held it in 6 quarters since.
Bowen Hanes & Co's Boston Scientific position peaked at $44.5M in Q2 2025.
1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Bowen Hanes & Co's 13F filing for Q1 2026, filed 14 May 2026.